Menu
Back to User profile » Dr Courtney Crim
Papers published by Dr Courtney Crim:
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials
Hanania NA, Caveney S, Soule T, Tombs L, Lettis S, Crim C, Mannino DM, Patel H, Boucot IH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1925-1938
Published Date: 24 June 2021
Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness
Horne BD, Ali R, Midwinter D, Scott-Wilson C, Crim C, Miller BE, Rubin DB
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:41-51
Published Date: 7 January 2021
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease
Horne BD, Hegewald MJ, Crim C, Rea S, Bair TL, Blagev DP
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1741-1750
Published Date: 20 July 2020
FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1135-1142
Published Date: 20 May 2020
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
Crim C, Watkins ML, Bateman ED, Feldman GJ, Schenkenberger I, Kerwin EM, Crawford C, Pudi K, Ho S, Baidoo C, Castro-Santamaria R
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:615-629
Published Date: 8 March 2019
Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials
Rubin DB, Ahmad HA, O'Neal M, Bennett S, Lettis S, Galkin DV, Crim C
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:189-201
Published Date: 8 January 2018
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
Bhatt SP, Dransfield MT, Cockcroft JR, Wang-Jairaj J, Midwinter DA, Rubin DB, Scott-Wilson CA, Crim C
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:351-365
Published Date: 19 January 2017
Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
Covelli H, Pek B, Schenkenberger I, Scott-Wilson C, Emmett A, Crim C
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1-12
Published Date: 18 December 2015